My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc. - Common Stock (NQ:POAI)

0.7970 -0.1530 (-16.11%)
Streaming Delayed Price Updated: 3:09 PM EDT, Sep 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Predictive Oncology Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside
Via Stocktwits
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million. 
Via Benzinga
Predictive Oncology Announces 1-for-15 Reverse Stock Split
Common Stock Will Begin Trading on Split-Adjusted Basis on September 30, 2025 
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients
Collaboration builds upon positive results utilizing Predictive Oncology’s AI platform to identify new indications for existing drugs 
From Predictive Oncology Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI
From Kahn Swick & Foti, LLC
Via GlobeNewswire
POAI Reports Earnings
Via The Motley Fool
Topics Artificial Intelligence
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp
Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapies 
From Predictive Oncology Inc.
Via GlobeNewswire
Court Denies Renovaro Motion for an Expedited Trial in July
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish
Renovaro said the Delaware Court of Chancery had approved an expedited trial schedule for the lawsuit it filed to enforce a binding merger agreement with Predictive Oncology. 
Via Stocktwits
Topics Artificial Intelligence Lawsuit
UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
Company Leverages More Than Twenty Years of Drug Response Data Derived from Massive Biobank of Live Cell Tumor Samples 
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health"
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Predictive Oncology Inc.
Via GlobeNewswire
Predictive Oncology Develops Novel Approach to Identifying Clinically Viable Abandoned Drugs
From Predictive Oncology Inc.
Via GlobeNewswire
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:POAI),(NYSE:TDOC),(NASDAQ:GEHC) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
12 Health Care Stocks Moving In Friday's After-Market Session
 
Via Benzinga
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
From Renovaro Inc
Via GlobeNewswire
Healthcare Diagnostics Sector Witnessing Significant Growth in Artificial Intelligence Based Technologies
From FN Media Group LLC
Via GlobeNewswire
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update
Company continues to progress toward the signing of a definitive merger agreement with Renovaro 
From Predictive Oncology Inc.
Via GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
From FN Media Group LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.